#VisualAbstract: First-Line Sugemalimab Plus Chemotherapy Provides Survival Benefit in Advanced Gastric Cancer
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced...
#VisualAbstract: Laparoscopic Parenchymal Preserving Liver Resections in the Posterosuperior Segments Reduces Time to Recovery
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be...
#VisualAbstract: Pridopidine Does Not Impact the Progression of Amyotrophic Lateral Sclerosis
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced...
#VisualAbstract: Addition of Aerobic Physical Activity to Resistance Exercise Does Not Improve Pain or Function in Hip Osteoarthritis
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be...
#VisualAbstract: Nerinetide Does Not Improve Outcomes in Acute Ischaemic Stroke in Patients Undergoing Endovascular Thrombectomy
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be...
#VisualAbstract: Simvastatin and Rifaximin Does Not Improve Outcomes in Decompensated Cirrhosis
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced...
#VisualAbstract: Endovascular Treatment Does Not Improve Outcomes in Stroke Due to Occlusion of Medium or Distal Vessels
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced...
#VisualAbstract: Apixaban is Superior to Aspirin for Stroke Prevention in People with Subclinical Atrial Fibrillation
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be...
#VisualAbstract: Adjuvant Atezolizumab Does Not Provide Benefit in Early Triple-Negative Breast Cancer
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced...
#VisualAbstract: Abelacimab is Safer Than Rivaroxaban in Patients with Atrial Fibrillation
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced...
